VANGUARD GROUP INC 13D and 13G filings for Charles River Laboratories International, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:01 pm Purchase | 2023-12-29 | 13G | Charles River Laboratories International, Inc. CRL | VANGUARD GROUP INC | 5,980,236 11.660% | 23,276 (+0.39%) | Filing |
| 2023-02-09 11:12 am Purchase | 2022-12-30 | 13G | Charles River Laboratories International, Inc. CRL | VANGUARD GROUP INC | 5,956,960 11.710% | 87,835 (+1.50%) | Filing |
| 2022-02-09 3:33 pm Purchase | 2021-12-31 | 13G | Charles River Laboratories International, Inc. CRL | VANGUARD GROUP INC | 5,869,125 11.630% | 841,221 (+16.73%) | Filing |
| 2021-02-10 10:46 am Sale | 2020-12-31 | 13G | Charles River Laboratories International, Inc. CRL | VANGUARD GROUP INC | 5,027,904 10.110% | -291,472 (-5.48%) | Filing |